All Substitutes
Loading...
Disclaimer
Did you find this information helpful?
![EMBREMMA 0 EMBREMMA 0](https://assets.mrmed.in/product-images/product-images-1692169588444-353784322-EMBREMMA%200.5MG%20INJECTION_100554_1.jpg)
![EMBREMMA 0 EMBREMMA 0](https://assets.mrmed.in/product-images/product-images-1692169588448-602755650-EMBREMMA%200.5MG%20INJECTION_100554_2.jpg)
![EMBREMMA 0 EMBREMMA 0](https://assets.mrmed.in/product-images/product-images-1692169588444-353784322-EMBREMMA%200.5MG%20INJECTION_100554_1.jpg)
Embremma 0.5mg Injection
Prescription Required
Salt Composition : Eribulin
Manufacturer : EMCURE PHARMACEUTICALS LTD
Origin of Medicine : India
1 Vial(s) Of 2ml
PAP Information : Buy 3, Get 1 Free. Contact us for latest updates.
Program Overview: EMCURE PHARMACEUTICALS LTD, Patient Assistance Program (PAP), is dedicated to helping patients in need of Embremma 0.5mg injection. The program aims to provide eligible patients with access to the medication at a more affordable cost.
Program Benefits: Purchase 1 vial of Embremma 0.5mg injection, and you will receive 1 free additional vial. Therefore, if eligible, you will have to pay only Rs. 15,362 for 2 vials, which is Rs. 7,681 per vial.
With MrMed's MRP discount of Rs.4,138 per vial and Emcure’s PAP program, the overall savings is over Rs. 23 thousand per purchase.
Contact us for the latest updates on this exclusive offer.
Eligibility Criteria: To qualify for the Embremma Patient Assistance Program (PAP), you must meet specific criteria, including having a valid prescription for Eribulin 0.5mg from a medical oncologist and being an Indian patient with a valid identity card. Eligibility is determined based on the diagnosed condition and program-specific requirements.
Contact Information: If you have any questions or need assistance with the application process, our dedicated patient support team is here to help. You can reach us by phone at 89391 69999 or email us at [email protected].
Please note that MrMed is not involved in the PAP program. They offer free consultations to patients to provide information about the program. Patients eligible for the PAP program by Emcure can avail of it without having to purchase the medication from MrMed.
Patient Assistance Programs
Program Overview: EMCURE PHARMACEUTICALS LTD, Patient Assistance Program (PAP), is dedicated to helping patients in need of Embremma 0.5mg injection. The program aims to provide eligible patients with access to the medication at a more affordable cost.
Program Benefits: Purchase 1 vial of Embremma 0.5mg injection, and you will receive 1 free additional vial. Therefore, if eligible, you will have to pay only Rs. 15,362 for 2 vials, which is Rs. 7,681 per vial.
With MrMed's MRP discount of Rs.4,138 per vial and Emcure’s PAP program, the overall savings is over Rs. 23 thousand per purchase.
Contact us for the latest updates on this exclusive offer.
Eligibility Criteria: To qualify for the Embremma Patient Assistance Program (PAP), you must meet specific criteria, including having a valid prescription for Eribulin 0.5mg from a medical oncologist and being an Indian patient with a valid identity card. Eligibility is determined based on the diagnosed condition and program-specific requirements.
Contact Information: If you have any questions or need assistance with the application process, our dedicated patient support team is here to help. You can reach us by phone at 89391 69999 or email us at [email protected].
Please note that MrMed is not involved in the PAP program. They offer free consultations to patients to provide information about the program. Patients eligible for the PAP program by Emcure can avail of it without having to purchase the medication from MrMed.
Introduction to Embremma 0.5mg Injection
Embremma 0.5mg Injection is a chemotherapy drug that contains the active substance eribulin, which belongs to the class of antineoplastic agents. Embremma 0.5mg Injection is used in adults for advanced breast cancer or liposarcoma (a type of cancer originating from fat tissue) when other treatments have stopped working.
It is not recommended to take Embremma 0.5mg Injection if you are allergic to Eribulin or any of its other ingredients. Consult your doctor if you believe this applies to you. It is not recommended for children and adolescents younger than 18 years since the effects of Embremma 0.5mg Injection in this population are unknown. Before starting the treatment, you should inform your physician if you have fever, infections, liver, or heart problems. Before starting the treatment, give a detailed account of your medical history and medications.
Uses of Embremma 0.5mg Injection
- Advanced breast cancer
- Liposarcoma
Therapeutic Effects of Embremma 0.5mg Injection
Embremma 0.5mg Injection stops the growth and spread of cancer cells, specifically targeting the growth phase of microtubules, which are structures that help cells divide. It prevents them from growing without interfering with their shrinking phase. Additionally, it causes tubulin, a protein essential for cell division, to clump together in a way that disrupts cell division. This ultimately leads to the blockage of the cell cycle (G2/M phase), disrupting the formation of structures necessary for cell division (mitotic spindles) and triggering cell death through apoptosis.
Interaction of Embremma 0.5mg Injection with other drugs
Inform your doctor about all the medicines you take, including prescription, over-the-counter, nutritional or vitamin supplements, and herbal products. Certain medications may interact with Embremma 0.5mg Injection and reduce effectiveness by causing undesirable side effects.
More Information about Embremma 0.5mg Injection
- Store Embremma 0.5mg Injection at 25°C.
- Keep it in its original packaging.
- Protect it from light and moisture.
- Keep it out of the reach of children and pets.
How to consume Embremma 0.5mg Injection
Embremma 0.5mg Injection will be given to you by your healthcare provider. It is injected directly into a vein (intravenous infusion) in a cycle. Your healthcare provider determines the dose, duration, and frequency based on your age, body weight, and severity of your condition. If you forget or miss your Embremma 0.5mg Injection cycle dose, make another appointment as soon as possible. Do not wait until your next planned visit. Do not stop the treatment without physician advice.
Safety Advices for Embremma 0.5mg Injection
Pregnancy
Embremma 0.5mg Injection is unsafe for pregnant women as it may cause fetal harm. Inform your doctor promptly if you are pregnant, planning for pregnancy, or think you may get pregnant before starting the treatment with Embremma 0.5mg Injection.
Breast Feeding
Embremma 0.5mg Injection is not recommended while breastfeeding since it is unknown whether it passes through breast milk. Inform your doctor if you are breastfeeding or planning to breastfeed before starting the treatment with Embremma 0.5mg Injection.
Lungs
Embremma 0.5mg Injection can cause side effects like blood clots in the lungs and inflammation of the lungs. Inform your doctor if you have ever had lung disorders before starting the treatment, as its symptoms may worsen with Embremma 0.5mg Injection.
Liver
Embremma 0.5mg Injection can affect the liver's normal functioning, causing abnormalities in liver function tests. Hence, you should inform your healthcare provider if you have pre-existing liver problems before starting this treatment.
Alcohol
Embremma 0.5mg Injection contains small amounts of alcohol. Hence, it is generally recommended that patients taking Embremma 0.5mg Injection avoid or limit their alcohol intake, as alcohol can enhance the risk of liver damage and exacerbate any liver-related side effects of Embremma 0.5mg Injection.
Driving
Embremma 0.5mg Injection causes tiredness and dizziness, which may impair your ability to drive, cycle, or operate machinery. Avoid doing so until the treatment.
Side Effects of Embremma 0.5mg Injection
Side effects are unwanted symptoms that occur due to medicines. Even though all drugs cause side effects, not everyone gets them.
Serious
- Sepsis (severe infection)
- Severe allergic reaction
- Serious skin conditions (Stevens-Johnson syndrome)
Common
- Decrease in the number of white blood cells or red blood cells
- Tiredness or weakness
- Nausea, vomiting, constipation, diarrhea
- Numbness, tingling or prickling sensations
- Fever
- Loss of appetite, weight loss
- Difficulty breathing, cough
- Pain in the joints, muscles, and back
- Headache
- Hair loss
Word of Advice
Your doctor will monitor your liver function via blood tests and assess your heart function before and during treatment. If you are a woman who could become pregnant, ensure reliable birth control while taking Embremma 0.5mg Injection and for at least three months after stopping it. Consult your doctor for guidance on alternative contraception methods to avoid pregnancy during this treatment. Talk to your oncologist if you need dental treatment. Always tell your dentist you are having cancer treatment. This treatment can affect fertility in men and women. If you are worried about this, it is important to talk with your doctor before you start treatment.
If you experience diarrhea while taking Embremma 0.5mg Injection, try to drink at least 2 liters of fluids daily and avoid alcohol, caffeine, milk products, and high-fat and high-fiber foods. If constipation occurs, increase your fluid intake, consume high-fiber foods, and engage in regular gentle exercise. Contact the hospital for advice; your doctor may prescribe laxatives to help constipation. If you notice a loss of appetite, don't worry if it lasts for a day or two, but if it persists or if you're losing weight, inform your nurse or dietitian for guidance. They may recommend supplements, dietary changes, or adjustments to eating habits to address these issues.
FAQs
Q 1. What is the most important information I should know while taking Embremma 0.5mg Injection?
Embremma 0.5mg Injection can cause serious adverse effects such as low white blood cell count, numbness, tingling, and pain in the hands and feet. Inform your physician immediately if you face any of these symptoms.
Q 2. Does Embremma 0.5mg Injection cause infertility?
Yes, Embremma 0.5mg Injection causes infertility in men and women. It is necessary to use effective birth control methods during the treatment and for three weeks (females) and 14 weeks (males) after the final dose of the injection.
Q 3. Is hair loss caused by Embremma 0.5mg Injection reversible?
Hair loss is a common side effect of Embremma 0.5mg Injection Injection. It is reversible, but it depends totally on the severity of the hair loss and varies from person to person. Consult your doctor if you have severe hair loss.
Q 4. Do I have to follow any special dietary requirements while taking Embremma 0.5mg Injection?
It depends upon the severity of the disease condition. You can have a normal diet until your physician tells you to follow any special food or diet chart. Check with your doctor if you have any nutrition concerns.
Q 5. What should I do if I miss taking Embremma 0.5mg Injection?
It is important to get the injection at the right time. If you missed your appointment, contact your healthcare provider and schedule your dosing immediately. Keep follow-ups on your next schedule.
Fact Box of Embremma 0.5mg Injection
Molecule name: Eribulin | Therapeutic class: Anticancer |
Pharmacological class: Monoclonal antibody-drug conjugate | Indications: 1. Advanced breast cancer 2. Liposarcoma |
Dosage form: Injections | Habit forming: No |
References
- Eisai Europe Limited, Electronic medicines compendium (EMC), [Revised on Jan 2023] [Accessed on Feb 2024], https://www.medicines.org.uk/emc/files/pil.4517.pdf
- Genentech, Inc, US Food and Drug Administration (FDA), [Revised on Jan 2016], [Accessed on Feb 2024], https://www.accessdata.fda.gov/drugsatfda_docs/label/2016/201532s015lbl.pdf
- Goodman & Gilman's Pharmacological Basis of Therapeutics, Pharmacotherapy of neoplastic drugs, 13th edition, 2018, 1187.
Disclaimer
MrMed’s primary intention is to ensure that its consumers get information that is reviewed by experts, accurate and trustworthy. The information and contents of this website are for informational purposes only. They are not intended to be a substitute for professional medical advice, diagnosis, or treatment. Please seek the advice of your doctor and discuss all your queries related to any disease or medicine. Do not disregard professional medical advice or delay in seeking it because of something you have read on MrMed. Our mission is to support, not replace, the doctor-patient relationship.